The 1 Stock Most Likely to Win From a Potentially Game-Changing Coronavirus Discovery

It's easy to underappreciate just how much progress has been made in researching SARS-CoV-2, the novel coronavirus that causes COVID-19. During the last major pandemic to hit the U.S. (the 1918 influenza pandemic), scientists didn't even conclusively determine that a virus -- instead of a bacterium -- caused the deadly flu until 1930, more than a decade after the end of the pandemic.

Earlier this year, the genomic sequence for SARS-CoV-2 was mapped. That paved the way for the development of diagnostic tests as well as potential treatments and vaccines. The progress has been astounding compared with previous viral outbreaks (and not just those from a century ago).

A team of U.K. researchers recently unveiled a new major development that just might be a game-changer in how COVID-19 is treated. And there's one stock that's most likely to win from this latest breakthrough.

Continue reading

Source Fool.com